These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 17204667

  • 1. Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice.
    Bostrom MA, Boyanovsky BB, Jordan CT, Wadsworth MP, Taatjes DJ, de Beer FC, Webb NR.
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):600-6. PubMed ID: 17204667
    [Abstract] [Full Text] [Related]

  • 2. The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo.
    Boyanovsky B, Zack M, Forrest K, Webb NR.
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):532-8. PubMed ID: 19164803
    [Abstract] [Full Text] [Related]

  • 3. Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans.
    Boyanovsky BB, van der Westhuyzen DR, Webb NR.
    J Biol Chem; 2005 Sep 23; 280(38):32746-52. PubMed ID: 16040605
    [Abstract] [Full Text] [Related]

  • 4. Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet.
    Rosengren B, Peilot H, Umaerus M, Jönsson-Rylander AC, Mattsson-Hultén L, Hallberg C, Cronet P, Rodriguez-Lee M, Hurt-Camejo E.
    Arterioscler Thromb Vasc Biol; 2006 Jul 23; 26(7):1579-85. PubMed ID: 16601231
    [Abstract] [Full Text] [Related]

  • 5. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation.
    Wooton-Kee CR, Boyanovsky BB, Nasser MS, de Villiers WJ, Webb NR.
    Arterioscler Thromb Vasc Biol; 2004 Apr 23; 24(4):762-7. PubMed ID: 14962950
    [Abstract] [Full Text] [Related]

  • 6. Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress.
    Tietge UJ, Pratico D, Ding T, Funk CD, Hildebrand RB, Van Berkel T, Van Eck M.
    J Lipid Res; 2005 Aug 23; 46(8):1604-14. PubMed ID: 15897607
    [Abstract] [Full Text] [Related]

  • 7. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E, Gautier T, Rosengren B, Dikkers A, Behrendt M, Grass DS, Rader DJ, Tietge UJ.
    Arterioscler Thromb Vasc Biol; 2013 Dec 23; 33(12):2707-14. PubMed ID: 24115030
    [Abstract] [Full Text] [Related]

  • 8. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
    Leitinger N, Watson AD, Hama SY, Ivandic B, Qiao JH, Huber J, Faull KF, Grass DS, Navab M, Fogelman AM, de Beer FC, Lusis AJ, Berliner JA.
    Arterioscler Thromb Vasc Biol; 1999 May 23; 19(5):1291-8. PubMed ID: 10323782
    [Abstract] [Full Text] [Related]

  • 9. Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice.
    Webb NR, Bostrom MA, Szilvassy SJ, van der Westhuyzen DR, Daugherty A, de Beer FC.
    Arterioscler Thromb Vasc Biol; 2003 Feb 01; 23(2):263-8. PubMed ID: 12588769
    [Abstract] [Full Text] [Related]

  • 10. Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism.
    de Beer FC, de Beer MC, van der Westhuyzen DR, Castellani LW, Lusis AJ, Swanson ME, Grass DS.
    J Lipid Res; 1997 Nov 01; 38(11):2232-9. PubMed ID: 9392421
    [Abstract] [Full Text] [Related]

  • 11. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
    Hanasaki K, Yamada K, Yamamoto S, Ishimoto Y, Saiga A, Ono T, Ikeda M, Notoya M, Kamitani S, Arita H.
    J Biol Chem; 2002 Aug 09; 277(32):29116-24. PubMed ID: 12021277
    [Abstract] [Full Text] [Related]

  • 12. Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition.
    Ghesquiere SA, Gijbels MJ, Anthonsen M, van Gorp PJ, van der Made I, Johansen B, Hofker MH, de Winther MP.
    J Lipid Res; 2005 Feb 09; 46(2):201-10. PubMed ID: 15576846
    [Abstract] [Full Text] [Related]

  • 13. New phospholipase A(2) isozymes with a potential role in atherosclerosis.
    Murakami M, Kudo I.
    Curr Opin Lipidol; 2003 Oct 09; 14(5):431-6. PubMed ID: 14501581
    [Abstract] [Full Text] [Related]

  • 14. Group X secreted phospholipase A2 limits the development of atherosclerosis in LDL receptor-null mice.
    Ait-Oufella H, Herbin O, Lahoute C, Coatrieux C, Loyer X, Joffre J, Laurans L, Ramkhelawon B, Blanc-Brude O, Karabina S, Girard CA, Payré C, Yamamoto K, Binder CJ, Murakami M, Tedgui A, Lambeau G, Mallat Z.
    Arterioscler Thromb Vasc Biol; 2013 Mar 09; 33(3):466-73. PubMed ID: 23349189
    [Abstract] [Full Text] [Related]

  • 15. Secretory phospholipase A2 enzymes in atherogenesis.
    Webb NR.
    Curr Opin Lipidol; 2005 Jun 09; 16(3):341-4. PubMed ID: 15891396
    [Abstract] [Full Text] [Related]

  • 16. Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.
    Ivandic B, Castellani LW, Wang XP, Qiao JH, Mehrabian M, Navab M, Fogelman AM, Grass DS, Swanson ME, de Beer MC, de Beer F, Lusis AJ.
    Arterioscler Thromb Vasc Biol; 1999 May 09; 19(5):1284-90. PubMed ID: 10323781
    [Abstract] [Full Text] [Related]

  • 17. Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis.
    Schiering A, Menschikowski M, Mueller E, Jaross W.
    Atherosclerosis; 1999 May 09; 144(1):73-8. PubMed ID: 10381280
    [Abstract] [Full Text] [Related]

  • 18. Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2.
    Pruzanski W, Lambeau L, Lazdunsky M, Cho W, Kopilov J, Kuksis A.
    Biochim Biophys Acta; 2005 Sep 05; 1736(1):38-50. PubMed ID: 16122976
    [Abstract] [Full Text] [Related]

  • 19. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
    Morioka Y, Saiga A, Yokota Y, Suzuki N, Ikeda M, Ono T, Nakano K, Fujii N, Ishizaki J, Arita H, Hanasaki K.
    Arch Biochem Biophys; 2000 Sep 01; 381(1):31-42. PubMed ID: 11019817
    [Abstract] [Full Text] [Related]

  • 20. Activated platelets contribute to oxidized low-density lipoproteins and dysfunctional high-density lipoproteins through a phospholipase A2-dependent mechanism.
    Blache D, Gautier T, Tietge UJ, Lagrost L.
    FASEB J; 2012 Feb 01; 26(2):927-37. PubMed ID: 22042222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.